Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

By Mooij P.   Heeney J.L.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 304-321

Elsevier

Access to resources Recommend Favorite

Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines

By Scheiblhofer Sandra  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 6, 2013-06 ,pp. : 761-773

Informa Healthcare

Access to resources Recommend Favorite

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy

By Liu W.J.   Zhao K.-N.   Gao F.G.   Leggatt G.R.   Fernando G.J.P.   Frazer I.H.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 862-869

Elsevier

Access to resources Recommend Favorite

Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application

By Betti M.   Voltan R.   Marchisio M.   Mantovani I.   Boarini C.   Nappi F.   Ensoli B.   Caputo A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3408-3419

Elsevier

Access to resources Recommend Favorite

The basis for HIV immunotherapeutic vaccines

By Peters B.S.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 688-705

Elsevier

Access to resources Recommend Favorite